AzTrials
AzTrials

PhenylketonuriaNCT07526909

Effect of Different Meal Types Given Before Exercise on Plasma Amino Acid Levels and Metabolic Control Parameters in Classical Phenylketonuria Patients Undergoing Aerobic and Resistance Exercises

A study testing Aerobic Exercise, Resistance Exercise and Water in people with Phenylketonuria, run by Hacettepe University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will be the first in the literature to evaluate the relationship between aerobic and resistance exercises, plasma amino acid levels, metabolic control of patients, and the metabolic response to exercise with different types of meals in patients with Phenylketonuria (PKU). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Phenylketonuria
What is being tested?
Aerobic Exercise, Resistance Exercise and Water
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Oct 2025to 15 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Be over 18 years old,
  • Having a classic FKU diagnosis,
  • Not being actively engaged in sports,
  • Not having any other existing diseases,
  • Not having an active infection,
  • Have a BMI in the range of 20-28 kg/m2 within the last 3 months,
  • Agreeing to consume test meals and provide blood samples for parameters that will evaluate plasma amino acid levels as part of the research
  • Being willing to participate in this study

Who cannot join

  • Presence of a chronic disease accompanying FKU disease (endocrine, etc.)
  • The individual with FKU has mental retardation or is deemed unfit for work based on psychomotor assessment,
  • Recent weight loss, history of hospitalisation, a past infection, or a diagnosed illness
  • Use of drugs or alcohol that alter protein and energy metabolism (e.g., corticosteroids, etc.)
  • Pregnancy status
  • Smoking habits The considerations to be taken into account when planning the day/date of the test are as follows.
  • Having engaged in heavy exercise or sports within 24 hours before the application of test diets,
  • Being in the menstrual period for female patients.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Hacettepe University

    Ankara, Ankara, 06100

Other trials in Turkey (Türkiye)

About this study

This study will be the first in the literature to evaluate the relationship between aerobic and resistance exercises, plasma amino acid levels, metabolic control of patients, and the metabolic response to exercise with different types of meals in patients with Phenylketonuria (PKU). In patients with phenylketonuria, the aim is to determine which pre-exercise dietary recommendations are more physiologically appropriate and ideal for achieving good metabolic control.

In the literature, there are very few studies examining the effects of exercise on plasma amino acid levels and metabolic parameters in PKU patients.

Read the detailed description

With this study, it is aimed to determine the effects of amino acid mixtures and carbohydrates on the plasma amino acid (phenylalanine, tyrosine, branched-chain aa, etc.) concentrations of patients with Classical Phenylketonuria (PKU) during different types of exercise and to investigate the hormonal responses to exercise. Adults (≥18 years) with classical phenylketonuria (PKU), who are on a phenylalanine-restricted diet and using amino acid substitutes, followed at the Hacettepe University Faculty of Medicine, Department of Pediatric Metabolism (outpatient clinic), will be assessed using the International Physical Activity Questionnaire (IPAQ) and dietary intake records. Based on these assessments and evaluation by sports medicine specialists, 10 participants deemed physically suitable will be allocated to the intervention group. The study, planned as a single-center, randomised, meal-based trial, will include 10 individuals with Classic Phenylketonuria (PKU) aged 18 and above, who are on a phenylalanine (PA) restricted diet and use an amino acid mixture.

All participants will be invited to the hospital on different days with a one-week interval for a total of 6 days. After a standard breakfast, they will perform 30 minutes of exercise before the amino acid mixture, amino acid+carbohydrate mixture, carbohydrate only, and water only, in two different types (3 aerobic + 3 resistance exercises) for a total of 6 exercises over 6 different weeks. On the first day of the study, the patients included will undergo blood FA level control, pre-exercise EKG measurement, and evaluation of exercise conditioning status. The daily protein requirement of the patients will be provided in the remaining meals, taking into account the amount consumed in their individual diets, using amino acid mixtures.

In the study, each patient will undergo both aerobic and resistance exercises separately in two different types of exercise (aerobic and resistance). Prior to these exercises, three different test diets (water only, carbohydrate only, carbohydrate+protein test diets) will be administered to monitor the patients' blood amino acid levels and some metabolic control parameters. Therefore, patients will have their blood profiles monitored for 2 hours each time they receive one type of exercise and one test diet once a week for 6 weeks (the washout period is 1 week). Before the exercise, 3 test diets will be administered with 2 types of exercise on 6 different days, and the analyses of plasma amino acid concentration, glucose, insulin, lactate, BUN, and creatinine levels will be evaluated. The content of the given test diets will be prepared.

Before exercise, 3 test diets will be administered on 6 different days with 2 types of exercise, and the analyses of plasma amino acid concentration, glucose, insulin, lactate, BUN, and creatinine levels will be evaluated. The content of the provided test diets will be prepared to include only water, only carbohydrates, and a mixture of amino acids + carbohydrates. The prepared test diets will be presented to the patient both before resistance and aerobic exercise, resulting in a total of 6 different measurements.

The plasma aa levels of the patients will be examined before breakfast (120 minutes before exercise), at the start of exercise (0 minutes of exercise), and in venous blood at 30-minute intervals over a 2-hour period. Two hours before exercise, blood samples will be taken at 0, 30, 60, 90, and 120 minutes to investigate plasma amino acid, glucose, insulin, and lactate levels. It is aimed to investigate the levels of essential amino acids such as blood FA, Tyrosine (Tyr), and Branched-Chain Amino Acids (BCAA), as well as plasma glucose, insulin, lactate, BUN, and creatinine levels in patients with aerobic exercise. The obtained data will be evaluated using appropriate statistical analysis methods.

All participants will be invited to the hospital on different days with a one-week interval, and two hours after a standard breakfast (different test diets 10 minutes before exercise), they will receive 1 g/kg/hour of carbohydrates, 0.4 g/kg/hour of protein equivalent amino acids (aa) + 1 g/kg/hour of carbohydrates, and fasting (only hydration with 200 ml of water) to determine their role in post-exercise blood metabolic parameters. At the same time, these test diets will also be applied before aerobic and resistance exercises to examine the changes according to the type of exercise. In the literature, there are very few studies examining the effects of exercise on plasma amino acid levels and metabolic parameters in PKU patients. Determining which dietary recommendations before exercise are more physiologically appropriate and ideal for achieving good metabolic control in patients with phenylketonuria will be guiding.

Conditions
Phenylketonuria
Being tested
Aerobic Exercise, Resistance Exercise, Water, Carbohydrates, Protein
Keywords
Phenylketonuria, Phenylalanine, Low-protein diet, Exercise
Medical subject headings
Phenylketonurias, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aerobic ExerciseBehavioural

    Participants performed 30 minutes of moderate-intensity aerobic exercise on a treadmill at 80% of maximum heart rate with a 3% incline.

  • Resistance ExerciseBehavioural

    Participants performed a resistance exercise session including 3 sets of 10 repetitions of crunch, push-up, forward lunge, and squat exercises.

  • WaterOther

    Participants consumed 200 ml of water prior to the exercise session.

  • CarbohydratesDietary supplement

    Participants consumed carbohydrates at a dose of 1 g/kg/hour prior to the exercise session.

  • ProteinDietary supplement

    Participants consumed protein equivalent to 0.4 g/kg/hour (amino acids) prior to the exercise session.

Study groups in NCT07526909
Study groupRoleWhat they receive
Aerobic Exercise + WaterExperimentalParticipants performed aerobic exercise after consuming only water.
Receives: Behavioral: Aerobic Exercise; Other: Water
Aerobic Exercise + CarbohydratesExperimentalParticipants performed aerobic exercise after consuming carbohydrates with water.
Receives: Behavioral: Aerobic Exercise; Other: Water; Dietary Supplement: Carbohydrates
Aerobic Exercise + Carbohydrates + ProteinExperimentalParticipants performed aerobic exercise after consuming carbohydrates and protein with water.
Receives: Behavioral: Aerobic Exercise; Other: Water; Dietary Supplement: Carbohydrates; Dietary Supplement: Protein
Resistance Exercise + WaterExperimentalParticipants performed resistance exercise after consuming only water.
Receives: Behavioral: Resistance Exercise; Other: Water
Resistance Exercise + CarbohydratesExperimentalParticipants performed resistance exercise after consuming carbohydrates with water.
Receives: Behavioral: Resistance Exercise; Other: Water; Dietary Supplement: Carbohydrates
Resistance Exercise + Carbohydrates + ProteinExperimentalParticipants performed resistance exercise after consuming carbohydrates and protein with water.
Receives: Behavioral: Resistance Exercise; Other: Water; Dietary Supplement: Carbohydrates; Dietary Supplement: Protein

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Plasma Phenylalanine Levels

    Venous blood samples will be analyzed to determine changes in plasma phenylalanine concentrations in response to exercise and different pre-exercise meal types.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

Secondary outcomes (13)
  1. Change in Plasma Tyrosine Levels

    Plasma tyrosine levels will be analyzed to assess amino acid metabolism.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  2. Change in Plasma Leucine Levels

    Plasma leucine levels will be measured to evaluate metabolic response to exercise and nutritional interventions.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  3. Change in Plasma Isoleucine Levels

    Plasma isoleucine levels will be measured to evaluate metabolic response to exercise and nutritional interventions.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  4. Change in Plasma Valine Levels

    Plasma valine levels will be measured to evaluate metabolic response to exercise and nutritional interventions.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  5. Change in Plasma Methionine Levels

    Plasma methionine levels will be analyzed to assess amino acid metabolism.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  6. Change in Plasma Threonine Levels

    Plasma threonine levels will be measured to evaluate metabolic response to exercise and nutritional interventions.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  7. Change in Plasma lysine Levels

    Plasma lysine levels will be measured to evaluate metabolic response to exercise and nutritional interventions.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  8. Change in Plasma Tryptophan Levels

    Plasma tryptophan levels will be analyzed to assess amino acid metabolism.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  9. Change in Serum Glucose Levels

    Serum glucose levels will be measured to assess metabolic response to exercise and nutritional interventions.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  10. Change in Serum Insulin Levels

    Serum insulin levels will be measured to assess hormonal response to exercise and nutritional interventions.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  11. Change in Blood Urea Nitrogen (BUN) Levels

    BUN levels will be measured to evaluate protein metabolism and renal response.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  12. Change in Serum Creatinine Levels

    Creatinine levels will be measured to evaluate renal function during the intervention.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

  13. Change in Serum Lactate Levels

    Serum lactate levels will be measured as an indicator of exercise intensity and metabolic response.

    Measured: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2026
  2. Study start1 Oct 2025
  3. Primary completion31 May 2026
  4. Study completion15 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
Two different exercises with three different diets, a total of six models in a crossover study.
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07526909
Sponsor's protocol ID
23-AKD-64
Status last verified
Sep 2026
First submitted
31 Mar 2026
Last updated
16 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The data can be obtained by contacting the author upon a reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing Aerobic Exercise, Resistance Exercise and Water in people with Phenylketonuria, run by Hacettepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Plasma Phenylalanine Levels (time frame: Baseline, pre-exercise, and post-exercise (0, 30, 60, 90, and 120 minutes)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in